Helse ·
Kirkenes Hospital Rations Water
I denne episoden
- Kirkenes Hospital Rations Water
- Merck Reports Sac-TMT Survival
- Roche Divarasib Impresses At ESMO
- Moderna Readies Cancer Vaccine Filing
- New Framework Guides Women’s Heart Care
- Incyte Reports Lasting Responses
Kilder
- NTB: Kirkenes sykehus i rød beredskap etter vannledningsbrudd
- STAT: STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
- BioSpace: ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer
- Biopharminternational: Merck and Kelun’s Sac-TMT Extends Survival by Nearly 7 Months in Pretreated Endometrial Cancer - BioPharm International
- STAT: STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
- STAT: STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
- STAT: STAT+: Five biotech updates to read after ESMO this weekend
- STAT: The 4 stages of women’s heart health: New framework for doctors and patients
- News: Women’s heart health gets a new playbook, starting in childhood - Northwestern Now News
- Newsroom: Leading health groups redefine heart health for girls and women - www.heart.org
- STAT: STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.